Treatment of breakthrough and prevention of refractory chemotherapy-induced nausea and vomiting in pediatric cancer patients: Clinical practice guideline update

被引:9
作者
Patel, Priya [1 ,2 ]
Robinson, Paula D. [1 ]
Phillips, Robert [3 ]
Baggott, Christina [4 ]
Devine, Katie [5 ]
Gibson, Paul [1 ,6 ]
Guilcher, Gregory M. T. [7 ,8 ]
Holdsworth, Mark T. [9 ]
Neumann, Eloise [10 ]
Orsey, Andrea D. [11 ,12 ]
Spinelli, Daniela
Thackray, Jennifer [13 ]
van de Wetering, Marianne [14 ]
Cabral, Sandra
Sung, Lillian [15 ,16 ]
Dupuis, L. Lee [2 ,16 ,17 ,18 ]
机构
[1] Pediat Oncol Grp Ontario, Toronto, ON, Canada
[2] Hosp Sick Children, Dept Pharm, Toronto, ON, Canada
[3] NHS Trust Leeds Teaching Hosp, Dept Haematol & Oncol, Leeds, England
[4] Stanford Canc Inst, Canc Clin Trials Off, Palo Alto, CA USA
[5] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
[6] McMaster Childrens Hosp, Div Haematol Oncol, Hamilton, ON, Canada
[7] Alberta Childrens Prov Gen Hosp, Sect Paediat Oncol & Blood & Marrow Transplant, Calgary, AB, Canada
[8] Univ Calgary, Dept Oncol & Paediat, Cumming Sch Med, Calgary, AB, Canada
[9] Univ New Mexico, Coll Pharm, Albuquerque, NM USA
[10] Birmingham Womens & Childrens Hosp, Birmingham, England
[11] Connecticut Childrens Med Ctr, Div Pediat Hematol Oncol, Hartford, CT USA
[12] Univ Connecticut, Dept Pediat, Sch Med, Farmington, CT USA
[13] Mem Sloan Kettering Canc Ctr, Dept Pharm, New York, NY USA
[14] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands
[15] Hosp Sick Children, Dept Paediat, Div Haematol Oncol, Toronto, ON, Canada
[16] Hosp Sick Children, Res Inst, Child Hlth Evaluat Sci, Toronto, ON, Canada
[17] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada
[18] Hosp Sick Children, Res Inst, 555Univ Ave, Toronto, ON M5G1X8, Canada
关键词
chemotherapy-induced nausea and vomiting; guideline; pediatric oncology; supportive care; ONDANSETRON; OLANZAPINE;
D O I
10.1002/pbc.30395
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This clinical practice guideline update provides recommendations for treating breakthrough chemotherapy-induced nausea and vomiting (CINV) and preventing refractory CINV in pediatric patients. Two systematic reviews of randomized controlled trials in adult and pediatric patients informed the recommendations. In patients with breakthrough CINV, escalation of antiemetic agents to those recommended for chemotherapy of the next higher level of emetogenic risk is strongly recommended. A similar recommendation to escalate therapy is made to prevent refractory CINV in patients who did not experience complete breakthrough CINV control and are receiving minimally or low emetogenic chemotherapy. A strong recommendation to use antiemetic agents that controlled breakthrough CINV for the prevention of refractory CINV is also made.
引用
收藏
页数:11
相关论文
共 23 条
  • [1] Oral Intake of Ginger for Chemotherapy-Induced Nausea and Vomiting Among Women With Breast Cancer
    Arslan, Muzeyyen
    Ozdemir, Leyla
    [J]. CLINICAL JOURNAL OF ONCOLOGY NURSING, 2015, 19 (05) : E92 - E97
  • [2] Mirtazapine, a dopamine receptor inhibitor, as a secondary prophylactic for delayed nausea and vomiting following highly emetogenic chemotherapy: an open label, randomized, multicenter phase III trial
    Cao, Jun
    Ouyang, Quchang
    Wang, Shusen
    Ragaz, Joseph
    Wang, Xiaojia
    Teng, Yuee
    Wang, Biyun
    Wang, Zhonghua
    Zhang, Jian
    Wang, Leiping
    Wu, Jiong
    Shao, Zhimin
    Hu, Xichun
    [J]. INVESTIGATIONAL NEW DRUGS, 2020, 38 (02) : 507 - 514
  • [3] Malus domestica reduces chemotherapy-induced nausea and vomiting: A randomized double-blind placebo-controlled clinical trial
    Darvishpour, Sharareh
    Avan, Razieh
    Azadbakht, Mohammad
    Maham, Monireh
    Akbari, Jafar
    Janbabaei, Ghasem
    Zaboli, Ehsan
    Amirabadizadeh, Ali Reza
    Salehifar, Ebrahim
    [J]. JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2021, 26 (01):
  • [4] Oral ondansetron is highly active as rescue antiemetic treatment for moderately emetogenic chemotherapy: results of a randomized phase II study
    Fabi, Alessandra
    Ciccarese, Mariangela
    Metro, Giulio
    Savarese, Antonella
    Giannarelli, Diana
    Nuzzo, Carmen M.
    Russillo, Michelangelo
    Sperduti, Isabella
    Carbone, Ilaria
    Bria, Emilio
    Cognetti, Francesco
    [J]. SUPPORTIVE CARE IN CANCER, 2008, 16 (12) : 1375 - 1380
  • [5] Guideline for the Treatment of Breakthrough and the Prevention of Refractory Chemotherapy-Induced Nausea and Vomiting in Children With Cancer
    Flank, Jacqueline
    Robinson, Paula D.
    Holdsworth, Mark
    Phillips, Robert
    Portwine, Carol
    Gibson, Paul
    Maan, Cathy
    Stefin, Nancy
    Sung, Lillian
    Dupuis, L. Lee
    [J]. PEDIATRIC BLOOD & CANCER, 2016, 63 (07) : 1144 - 1151
  • [6] GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
    Guyatt, Gordon H.
    Oxman, Andrew D.
    Vist, Gunn E.
    Kunz, Regina
    Falck-Ytter, Yngve
    Alonso-Coello, Pablo
    Schuenemann, Holger J.
    [J]. BRITISH MEDICAL JOURNAL, 2008, 336 (7650): : 924 - 926
  • [7] CONVINCING EVIDENCE FROM CONTROLLED AND UNCONTROLLED STUDIES ON THE LIPID-LOWERING EFFECT OF A STATIN
    Higgins, Julian
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (12):
  • [8] TRIMETHOBENZAMIDE HCL IN THE TREATMENT OF NAUSEA AND VOMITING ASSOCIATED WITH ANTI-NEOPLASTIC CHEMOTHERAPY
    HURLEY, JD
    ESHELMAN, FN
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 20 (5-6) : 352 - 356
  • [9] ONDANSETRON PLUS DEXAMETHASONE IS SUPERIOR TO ONDANSETRON ALONE IN THE PREVENTION OF EMESIS IN CHEMOTHERAPY-NAIVE AND PREVIOUSLY TREATED PATIENTS
    JOSS, RA
    BACCHI, M
    BUSER, K
    KIRCHNER, V
    NEUENSCHWANDER, H
    ORTH, B
    AAPRO, MS
    THURLIMANN, B
    [J]. ANNALS OF ONCOLOGY, 1994, 5 (03) : 253 - 258
  • [10] MEASUREMENT OF OBSERVER AGREEMENT FOR CATEGORICAL DATA
    LANDIS, JR
    KOCH, GG
    [J]. BIOMETRICS, 1977, 33 (01) : 159 - 174